HMGB1 and neoplasm: Previous researches have indicated that ICD can induce adaptive immune response against the antigens of dead or dying tumor cells through damage-associated molecular patterns (DAMPs), which include ATP release, calreticulin exposure, and HMGB1 (high mobility group box 1) secretion (9, 10).